Clinical Trial Update: Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing intravitreal and sub-tenon injections of Triamcinolone acetonide for macular edema in retinal disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Retinopathy
• Retinal Vein Occlusion

Drugs mentioned

• TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Macular Degeneration, Retinal Vein Occlusion | Phase 1 | Status: COMPLETED